semaglutide and sjogren's autoimmune disease as a potential therapeutic adjunct for reducing flare-ups in Sjögren's syndrome: A case report Ozempic and autoimmune disease: Safety – Sjögren syndrome | Nature Reviews

mechanisms and outcomes in humans are not established

284 In a phase 3 clinical trial, 284 eplontersen significantly reduced circulating TTR levels, mitigated nerve damage, and improved quality of life in ATTR-PN patients, resulting in its FDA approval in December 2023 for treating ATTR-PN

The goal is minimizing fetal exposure by stopping as soon as pregnancy is confirmed

This hormone helps balance blood sugar, reduce inflammation, calm appetite, and support metabolic health

By Alyx Arnett A class of weight-loss medications is gaining attention for its potential to become a pharmacological treatment option for obstructive sleep apnea (OSA) in patients with obesity

Dosage and Blood Sugar Control: How Dosage Affects Results The effectiveness of semaglutide in blood sugar control can vary depending on the dosage